Skip to search formSkip to main contentSkip to account menu

Todralazine

Known as: Hydrazinecarboxylic acid, 2-(1-phthalazinyl)-, ethyl ester, monohydrochloride, Todrazoline, Todralazine [Chemical/Ingredient] 
An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The Johns Hopkins Clinical Compound Library (JHCCL), a collection of Food and Drug Administration (FDA)-approved small molecules… 
2001
2001
An antimutagenic activity of fluphenazine, todralazine, anthocyanins and alkylresorcinols was established in a battery of short… 
2001
2001
The sensitivity of the available methods of apoptosis detection in lymphocyte cultures was tested. Cells were preincubated with… 
2000
2000
Todralazine, an antihypertensive drug from the hydrazinophthalazine group, significantly decreased the activities of benzo[a… 
1997
1997
Todralazine, an antihypertensive drug of the hydrazinoph-thalazine group, markedly decreased the mutagenic activity of potassium… 
Highly Cited
1996
Highly Cited
1996
We studied the effects of long-term antihypertensive treatment on endothelial function in renal resistance arteries from… 
Review
1996
Review
1996
The cause of fulminant hepatic failure is reported to be unknown in more than half the cases in Japan. We recently reviewed 23… 
1978
1978
3-Hydrazino-6-[N,N-bis (2-hydroxyethyl)amino]-pyridazine (L 6150) has been reported as an antihypertensive vasodilator drug. We…